Catharine Young: Why We Fund Science and Specifically mRNA Research
Catharine Young, Senior Fellow at Harvard T.H. Chan School of Public Health, shared a post on X about a paper by Sadeem Qdaisat et al. published in Nature Biomedical Engineering:
“This is why we fund science and specifically mRNA research.”
Title: Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
Authors: Sadeem Qdaisat, Brandon Wummer, Brian D. Stover, Dingpeng Zhang, James McGuiness, Frances Weidert, Jonathan Chardon-Robles, Adam Grippin, Anna DeVries, Chong Zhao, Christiano Marconi, Aida Karachi, Chao Xie, Gabriel Jobin, Ruixuan Liu, Stephen Michel, Xiaojie Ma, Rachel S. F. Moor, Christina von Roemeling, Duy T. Nguyen, Leighton Elliott, Nagheme Thomas, Arnav Barpujari, Hilary Geffrard, Yodarlynis Campaneria, Elizabeth Ogando-Rivas, Cathleen Rabideau, Dhruvkumar Soni, Jianping Huang, Sheila Carrera-Justiz, Kristianna Fredenburg, Natalie L. Silver, W. Gregory Sawyer, Maryam Rahman, John A. Ligon, Catherine T. Flores, Ji-Hyun Lee, Duane A. Mitchell, Paul Castillo, Hector R. Mendez-Gomez, Elias J. Sayour
You can read the Full Article on Nature Biomedical Engineering.
More posts featuring Catharine Young.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023